Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.
about
Glycolipid transfer protein interaction with bilayer vesicles: modulation by changing lipid composition.Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model.How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?Cell-associated transmission of HIV type 1 and other lentiviruses in small-animal modelsLipids and membrane microdomains in HIV-1 replicationA topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu miceOral epithelial cells and their interactions with HIV-1.Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy.Targeting Trojan Horse leukocytes for HIV prevention.Novel approaches to inhibiting HIV-1 replication.Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model.Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).Nanoparticle-based drug delivery to the vagina: a review.The Role of Lipids in Retrovirus Replication.Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1.Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities.Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape.Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.Non-specific microbicide product development: then and nowMonoclonal and Single Domain Antibodies Targeting β-Integrin Subunits Block Sexual Transmission of HIV-1 in In Vitro and In Vivo Model SystemsHIV-1 vaginal transmission: cell-free or cell-associated virus?Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cellsBlocking of HIV-1 infection by targeting CD4 to nonraft membrane domains.RNA interference for the treatment of papillomavirus disease.M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding.Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges.Setting the stage: host invasion by HIV.Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model.Novel humanized murine models for HIV research.Vaginal concentrations of lactic acid potently inactivate HIVGlycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection.Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention.Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.Efficiency of cell-free and cell-associated virus in mucosal transmission of human immunodeficiency virus type 1 and simian immunodeficiency virus.HIV infection of the genital mucosa in women.The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity.
P2860
Q24538790-E15E1119-CD0E-4FF0-A501-ECFB93CE68A1Q24815101-1E2E6808-48C2-4C00-9770-FDEE22145668Q25257230-2449FFB8-A558-4D66-86A0-0E9EC8DE0708Q26824485-1CB13A78-02B9-4B3A-BA11-1F7F0F8D5A7DQ27489393-6A21322C-E0F9-45D4-88AF-A8D19E5D58EFQ28478394-3B1264D1-27D3-42B6-A4A3-C75981AAF0CBQ30384510-FB556692-49B6-4F88-9AF5-BE2C61138EF8Q33405725-3BEE40AA-6799-4C65-AC9D-4BFE1C5E913EQ33518390-4BFF69B4-A31D-4752-9915-B4F5B459C8FBQ33624690-EC4DD7F5-8509-447A-9D98-250A6BB85162Q33654841-AF6CD2E3-D1F3-482F-9292-D66D5B18184BQ33784852-7A1C2E44-846C-4ADD-8C95-7F700E9BF164Q33967491-91B78BC6-7BF7-43AC-B983-C666D8689217Q34079533-0FF5D584-7B96-4F54-9A84-088EF5C46FC5Q34080779-06937B48-D23E-4D68-A59D-3A0B435E74DCQ34150951-C960BD13-4B49-41A9-8E00-A046183383CAQ34548621-1D6E636C-60C6-4105-A094-A6B9C3C47621Q34768558-4ED3BCAD-EDFA-45EA-8B93-CAC49320AE2AQ34975218-0B2FCAA5-926F-4AC2-95C2-218948744F19Q35000021-F3BE4891-E28F-4002-AC5B-54B9E31B03F3Q35005659-7652C1DB-46DC-4F86-89C4-27F4DE2FAF86Q35042478-DD088613-2FBA-415F-9019-7709B7797773Q35345283-DF515F79-CB64-4552-ADF1-85E11D99A669Q35591504-4D9B8383-FE44-4B43-A33F-0214A10C5A8CQ35897398-F9F9BFC8-FC61-489F-8486-5B45D564B076Q36318116-52B780F5-3D27-4047-9BAE-E309E769229EQ36370878-9A14DB9A-4A3F-4E2F-B02F-DF975D29CFC8Q36540664-3771E964-68C0-4C2B-A533-16C954A2D528Q36608485-CDD3506E-8EEF-4AAB-8BC7-45A529D928CFQ36748033-EFEFE22E-8AD6-4BF7-A348-AC56E6CD8EF9Q36983857-FE33658A-B050-4F72-9983-72FB6F038707Q37036786-5B446580-EAF5-4938-AA4E-41DFD8AFBAE0Q37084504-E77A9A1A-ADAD-4E66-AD70-ABA85CAF446BQ37095477-822A6064-8F3E-4D63-8A99-499D317BC77CQ37145333-2D4D5327-79E6-41AD-8E0D-4B2A80F00BC7Q37258271-F20FB80E-CC2B-4B9C-A9B9-3DE54507ABC5Q37280240-E22B590C-F286-4D15-81F4-E65F81433DF6Q37336708-07CD8638-40A4-4DD3-9764-E314E94C862FQ37370910-9EB25A99-8C1A-4477-8D20-446A2E9045C3Q37511571-128F28DB-8725-48AF-B05E-84616F5A550E
P2860
Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@ast
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@en
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@nl
type
label
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@ast
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@en
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@nl
prefLabel
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@ast
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@en
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@nl
P2093
P2860
P356
P1476
Vaginal transmission of cell-a ...... cal, membrane-modifying agent.
@en
P2093
James E K Hildreth
Karim Mehrazar
Kevin J Whaley
Kristen V Khanna
Larry Zeitlin
Leonard Shultz
Richard A Cone
Richard B Markham
Thomas R Moench
Timothy E Hoen
P2860
P304
P356
10.1172/JCI0213236
P407
P577
2002-01-01T00:00:00Z